Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association
医学
移植
心脏移植
肝移植
重症监护医学
肾
器官移植
心力衰竭
肾移植
心脏病学
内科学
作者
M. Kittleson,Kavita Sharma,Daniel C. Brennan,Xingxing S. Cheng,Sheryl L. Chow,Monica Colvin,Adam D. DeVore,Shannon M. Dunlay,Meg Fraser,Jacqueline Garonzik‐Wang,Prateeti Khazanie,Kevin Korenblat,Duc Thinh Pham
出处
期刊:Circulation [Lippincott Williams & Wilkins] 日期:2023-07-13卷期号:148 (7): 622-636被引量:29
Although heart transplantation is the preferred therapy for appropriate patients with advanced heart failure, the presence of concomitant renal or hepatic dysfunction can pose a barrier to isolated heart transplantation. Because donor organ supply limits the availability of organ transplantation, appropriate allocation of this scarce resource is essential; thus, clear guidance for simultaneous heart-kidney transplantation and simultaneous heart-liver transplantation is urgently required. The purposes of this scientific statement are (1) to describe the impact of pretransplantation renal and hepatic dysfunction on posttransplantation outcomes; (2) to discuss the assessment of pretransplantation renal and hepatic dysfunction; (3) to provide an approach to patient selection for simultaneous heart-kidney transplantation and simultaneous heart-liver transplantation and posttransplantation management; and (4) to explore the ethics of multiorgan transplantation.